Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
June 1-4, 2015 - Grand Hyatt, New York - USA
May 19-20, 2015 - InterContinental Vienna Hotel, Vienna - Austria
May 4-6, 2015 - DVFA Center, Frankfurt - Germany